| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 97 | 2024 | 20981 | 2.530 |
Why?
|
| Tamoxifen | 25 | 2022 | 965 | 1.900 |
Why?
|
| Receptors, Estrogen | 23 | 2024 | 2208 | 1.700 |
Why?
|
| Receptors, Interleukin | 9 | 2016 | 242 | 1.590 |
Why?
|
| Antineoplastic Agents, Hormonal | 20 | 2022 | 1520 | 1.570 |
Why?
|
| Homeodomain Proteins | 15 | 2022 | 2413 | 1.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 38 | 2018 | 8529 | 1.180 |
Why?
|
| Carcinoma, Ductal, Breast | 16 | 2018 | 1084 | 1.080 |
Why?
|
| Neoplasm Recurrence, Local | 15 | 2022 | 9278 | 0.990 |
Why?
|
| Gene Expression Profiling | 27 | 2017 | 9416 | 0.880 |
Why?
|
| Receptors, Progesterone | 9 | 2024 | 1129 | 0.860 |
Why?
|
| Receptor, erbB-2 | 14 | 2022 | 2553 | 0.660 |
Why?
|
| Lasers | 13 | 2010 | 952 | 0.650 |
Why?
|
| Microdissection | 10 | 2011 | 151 | 0.620 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 7 | 2013 | 926 | 0.610 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 9 | 1999 | 317 | 0.590 |
Why?
|
| Breast | 12 | 2023 | 1963 | 0.590 |
Why?
|
| Nitriles | 6 | 2024 | 971 | 0.570 |
Why?
|
| Prognosis | 28 | 2024 | 29672 | 0.560 |
Why?
|
| Lectins | 10 | 1999 | 489 | 0.560 |
Why?
|
| Triazoles | 6 | 2024 | 903 | 0.560 |
Why?
|
| Carcinoma in Situ | 7 | 2023 | 791 | 0.540 |
Why?
|
| Aromatase Inhibitors | 3 | 2024 | 513 | 0.520 |
Why?
|
| Receptors, Interleukin-17 | 10 | 2019 | 82 | 0.520 |
Why?
|
| Gynecomastia | 1 | 2016 | 86 | 0.500 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 13 | 2016 | 3776 | 0.500 |
Why?
|
| Drug Resistance, Neoplasm | 15 | 2019 | 5300 | 0.460 |
Why?
|
| Estrogens | 5 | 2022 | 1521 | 0.450 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 16 | 2016 | 4565 | 0.440 |
Why?
|
| Lymph Nodes | 5 | 2017 | 3461 | 0.430 |
Why?
|
| Influenza, Human | 1 | 2024 | 1521 | 0.430 |
Why?
|
| Carcinoma | 5 | 2023 | 2328 | 0.420 |
Why?
|
| Cell Adhesion Molecules | 9 | 1999 | 1603 | 0.400 |
Why?
|
| Zinc Fingers | 2 | 2011 | 575 | 0.390 |
Why?
|
| Carcinoma, Ductal | 1 | 2012 | 97 | 0.380 |
Why?
|
| Insulin-Secreting Cells | 7 | 2017 | 897 | 0.370 |
Why?
|
| BRCA1 Protein | 4 | 2014 | 1149 | 0.370 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2011 | 135 | 0.370 |
Why?
|
| Health Status Indicators | 1 | 2016 | 970 | 0.360 |
Why?
|
| Peptide Library | 2 | 2011 | 347 | 0.360 |
Why?
|
| Endometrial Neoplasms | 7 | 2017 | 1365 | 0.350 |
Why?
|
| Stromal Cells | 3 | 2014 | 1329 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2021 | 2820 | 0.330 |
Why?
|
| Adenocarcinoma, Clear Cell | 3 | 2017 | 217 | 0.320 |
Why?
|
| Neoplasm Metastasis | 11 | 2019 | 4908 | 0.320 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2018 | 943 | 0.320 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 145 | 0.320 |
Why?
|
| Choline Dehydrogenase | 2 | 2007 | 4 | 0.320 |
Why?
|
| Carcinoma, Lobular | 5 | 2021 | 480 | 0.300 |
Why?
|
| Antigens, CD | 9 | 1999 | 4008 | 0.300 |
Why?
|
| Leuprolide | 1 | 2009 | 312 | 0.290 |
Why?
|
| Sialic Acids | 3 | 1999 | 123 | 0.290 |
Why?
|
| Proteome | 4 | 2012 | 1856 | 0.290 |
Why?
|
| Chemotherapy, Adjuvant | 8 | 2022 | 3512 | 0.280 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2019 | 6482 | 0.280 |
Why?
|
| Female | 106 | 2024 | 392458 | 0.280 |
Why?
|
| Neoplasm Staging | 9 | 2017 | 11118 | 0.280 |
Why?
|
| Estrogen Receptor alpha | 5 | 2019 | 582 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2017 | 2892 | 0.270 |
Why?
|
| Pneumonia, Viral | 1 | 2024 | 3216 | 0.270 |
Why?
|
| Epithelial Cells | 10 | 2013 | 3666 | 0.270 |
Why?
|
| Cell Line, Tumor | 27 | 2017 | 16947 | 0.270 |
Why?
|
| Humans | 147 | 2024 | 761098 | 0.260 |
Why?
|
| Gene Expression | 4 | 2012 | 7567 | 0.260 |
Why?
|
| Genes, BRCA1 | 5 | 2010 | 754 | 0.240 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3594 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 9 | 2021 | 3591 | 0.240 |
Why?
|
| Receptors, Androgen | 2 | 2022 | 1077 | 0.230 |
Why?
|
| Proteomics | 7 | 2014 | 3836 | 0.220 |
Why?
|
| Sclerosis | 1 | 2004 | 210 | 0.220 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2011 | 410 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2017 | 2455 | 0.210 |
Why?
|
| Bone Neoplasms | 3 | 2018 | 2527 | 0.210 |
Why?
|
| Transcription Factors | 9 | 2016 | 12096 | 0.210 |
Why?
|
| Carrier Proteins | 7 | 2017 | 4933 | 0.210 |
Why?
|
| Disease-Free Survival | 8 | 2022 | 6817 | 0.210 |
Why?
|
| Mutation | 18 | 2017 | 30006 | 0.210 |
Why?
|
| Progesterone | 2 | 2022 | 742 | 0.210 |
Why?
|
| Breast Diseases | 2 | 2004 | 443 | 0.200 |
Why?
|
| Ki-67 Antigen | 2 | 2022 | 627 | 0.200 |
Why?
|
| Immunoenzyme Techniques | 4 | 2013 | 1703 | 0.200 |
Why?
|
| DNA Mutational Analysis | 12 | 2017 | 4109 | 0.190 |
Why?
|
| Ultrasonography, Mammary | 2 | 2016 | 239 | 0.190 |
Why?
|
| Antineoplastic Agents | 11 | 2017 | 13630 | 0.180 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 982 | 0.180 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2011 | 610 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2024 | 447 | 0.180 |
Why?
|
| Islets of Langerhans | 5 | 2011 | 1341 | 0.180 |
Why?
|
| Diagnosis, Differential | 5 | 2024 | 12975 | 0.180 |
Why?
|
| Cough | 1 | 2024 | 594 | 0.180 |
Why?
|
| DNA-Binding Proteins | 10 | 2013 | 9566 | 0.170 |
Why?
|
| RNA, Neoplasm | 7 | 2017 | 748 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2002 | 428 | 0.160 |
Why?
|
| Cytogenetic Analysis | 1 | 1999 | 270 | 0.160 |
Why?
|
| Cell Movement | 10 | 2016 | 5195 | 0.160 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2012 | 276 | 0.160 |
Why?
|
| Cell Line | 17 | 2014 | 15542 | 0.160 |
Why?
|
| Middle Aged | 40 | 2024 | 220835 | 0.160 |
Why?
|
| Neoplasms | 11 | 2017 | 22125 | 0.160 |
Why?
|
| DNA, Complementary | 3 | 2007 | 1989 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2010 | 2802 | 0.160 |
Why?
|
| RNA, Messenger | 18 | 2017 | 12743 | 0.160 |
Why?
|
| Gene Amplification | 5 | 2019 | 1084 | 0.150 |
Why?
|
| Disease Progression | 10 | 2014 | 13506 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 2057 | 0.150 |
Why?
|
| Octreotide | 2 | 2016 | 154 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2024 | 1566 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 256 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2004 | 913 | 0.150 |
Why?
|
| Muscle Neoplasms | 1 | 2019 | 130 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2024 | 1303 | 0.150 |
Why?
|
| Mastectomy, Segmental | 3 | 2009 | 955 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2019 | 11732 | 0.140 |
Why?
|
| Chest Pain | 1 | 2024 | 1095 | 0.140 |
Why?
|
| Gene Fusion | 2 | 2017 | 355 | 0.140 |
Why?
|
| Membrane Proteins | 8 | 2016 | 7844 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2024 | 767 | 0.140 |
Why?
|
| Fever | 1 | 2024 | 1618 | 0.140 |
Why?
|
| Nuclear Proteins | 7 | 2013 | 5781 | 0.140 |
Why?
|
| Transcription Factor TFIID | 1 | 2017 | 150 | 0.140 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2017 | 103 | 0.130 |
Why?
|
| Dyspnea | 1 | 2024 | 1347 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2024 | 2764 | 0.130 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 358 | 0.130 |
Why?
|
| Aged | 30 | 2024 | 169266 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 286 | 0.130 |
Why?
|
| Phthalazines | 2 | 2019 | 383 | 0.130 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 1559 | 0.130 |
Why?
|
| Loss of Heterozygosity | 4 | 2014 | 663 | 0.130 |
Why?
|
| Phosphoproteins | 3 | 2013 | 2443 | 0.130 |
Why?
|
| Receptors, Immunologic | 2 | 1999 | 1408 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 335 | 0.120 |
Why?
|
| Inositol Phosphates | 1 | 1995 | 175 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 282 | 0.120 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.120 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2016 | 195 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2011 | 4510 | 0.120 |
Why?
|
| Immunohistochemistry | 8 | 2014 | 11066 | 0.120 |
Why?
|
| Anoikis | 2 | 2005 | 48 | 0.120 |
Why?
|
| Hyperplasia | 3 | 2023 | 1150 | 0.120 |
Why?
|
| Cisplatin | 3 | 2010 | 1651 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2014 | 91 | 0.110 |
Why?
|
| Animals | 50 | 2021 | 168083 | 0.110 |
Why?
|
| Piperazines | 5 | 2019 | 2522 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2013 | 46 | 0.110 |
Why?
|
| B-Lymphocytes | 4 | 1995 | 4744 | 0.110 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2010 | 743 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 1111 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 13 | 2014 | 6123 | 0.110 |
Why?
|
| Cyclin D1 | 2 | 2006 | 451 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 1999 | 3696 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 517 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 1994 | 315 | 0.110 |
Why?
|
| Mice | 33 | 2021 | 81324 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2009 | 732 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2014 | 2426 | 0.110 |
Why?
|
| Cell Adhesion | 5 | 2007 | 3090 | 0.100 |
Why?
|
| Adult | 29 | 2024 | 221083 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2017 | 899 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 103 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 9025 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2018 | 1892 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 1900 | 0.100 |
Why?
|
| Indazoles | 1 | 2014 | 304 | 0.100 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 178 | 0.100 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2009 | 1784 | 0.100 |
Why?
|
| Acetyltransferases | 1 | 2013 | 231 | 0.100 |
Why?
|
| Pancreas | 2 | 2017 | 1685 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 426 | 0.100 |
Why?
|
| Case-Control Studies | 6 | 2013 | 22157 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 170 | 0.100 |
Why?
|
| Health Planning | 1 | 2013 | 231 | 0.100 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2011 | 60 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 5662 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2014 | 559 | 0.090 |
Why?
|
| RNA-Binding Proteins | 2 | 2017 | 1855 | 0.090 |
Why?
|
| Neoplasms, Experimental | 2 | 2010 | 1225 | 0.090 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 77 | 0.090 |
Why?
|
| Stress, Physiological | 2 | 2017 | 1406 | 0.090 |
Why?
|
| ROC Curve | 2 | 2012 | 3582 | 0.090 |
Why?
|
| Ligands | 5 | 2010 | 3266 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2023 | 2914 | 0.090 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 1984 | 0.090 |
Why?
|
| Prospective Studies | 7 | 2019 | 54419 | 0.090 |
Why?
|
| Collagen | 2 | 2014 | 2635 | 0.090 |
Why?
|
| Neoplasm Transplantation | 4 | 2019 | 2010 | 0.090 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 475 | 0.090 |
Why?
|
| Protein Kinases | 3 | 2009 | 1607 | 0.090 |
Why?
|
| Keratin-19 | 1 | 2010 | 33 | 0.090 |
Why?
|
| Protein Denaturation | 1 | 2010 | 241 | 0.090 |
Why?
|
| Molecular Sequence Data | 13 | 2017 | 17598 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2010 | 48 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2010 | 162 | 0.090 |
Why?
|
| Mastectomy | 2 | 2019 | 1817 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3591 | 0.080 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 363 | 0.080 |
Why?
|
| Chromatography, Liquid | 2 | 2011 | 982 | 0.080 |
Why?
|
| Postmenopause | 4 | 2016 | 2511 | 0.080 |
Why?
|
| Tyrosine | 3 | 2007 | 1422 | 0.080 |
Why?
|
| National Health Programs | 1 | 2013 | 440 | 0.080 |
Why?
|
| Receptor, Notch2 | 2 | 2007 | 87 | 0.080 |
Why?
|
| Transfection | 7 | 2016 | 5750 | 0.080 |
Why?
|
| Retrospective Studies | 11 | 2021 | 80673 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1731 | 0.080 |
Why?
|
| Antigens, Surface | 2 | 2010 | 1607 | 0.080 |
Why?
|
| Epithelium | 2 | 2012 | 1603 | 0.080 |
Why?
|
| Risk Factors | 7 | 2018 | 74219 | 0.080 |
Why?
|
| Treatment Outcome | 12 | 2024 | 64670 | 0.080 |
Why?
|
| Sialyltransferases | 3 | 1995 | 83 | 0.080 |
Why?
|
| Mutation, Missense | 3 | 2009 | 2567 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2014 | 506 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 2923 | 0.080 |
Why?
|
| Mice, Nude | 5 | 2017 | 3604 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2010 | 2656 | 0.080 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2008 | 31 | 0.080 |
Why?
|
| Risk Assessment | 6 | 2021 | 24013 | 0.080 |
Why?
|
| Apoptosis | 6 | 2017 | 9478 | 0.080 |
Why?
|
| Mice, SCID | 4 | 2017 | 2621 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2016 | 3665 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2008 | 107 | 0.080 |
Why?
|
| Mammography | 3 | 2009 | 2430 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 634 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 2 | 2017 | 2827 | 0.070 |
Why?
|
| Autoantigens | 2 | 2012 | 887 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2011 | 8303 | 0.070 |
Why?
|
| Genes, vpr | 1 | 2007 | 19 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 736 | 0.070 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2007 | 24 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2014 | 2864 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2010 | 459 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2014 | 12467 | 0.070 |
Why?
|
| Zebrafish | 1 | 2019 | 3001 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2706 | 0.070 |
Why?
|
| Genes, erbB-2 | 2 | 2007 | 162 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1348 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2011 | 788 | 0.070 |
Why?
|
| Goosecoid Protein | 1 | 2006 | 9 | 0.070 |
Why?
|
| Organizers, Embryonic | 1 | 2006 | 9 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1517 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1624 | 0.070 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 2731 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 833 | 0.070 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2007 | 103 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 4 | 2011 | 2635 | 0.070 |
Why?
|
| DNA Damage | 2 | 2014 | 2443 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 2008 | 1528 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2001 | 1057 | 0.070 |
Why?
|
| Quinazolines | 3 | 2014 | 1371 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2017 | 714 | 0.070 |
Why?
|
| Signal Transduction | 13 | 2016 | 23415 | 0.070 |
Why?
|
| Estradiol | 2 | 2011 | 1936 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3700 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6067 | 0.070 |
Why?
|
| DNA Repair | 2 | 2009 | 2041 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1391 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1249 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 370 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 619 | 0.070 |
Why?
|
| Lung Neoplasms | 4 | 2021 | 13382 | 0.060 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2007 | 238 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1994 | 1803 | 0.060 |
Why?
|
| Lung | 1 | 2024 | 9979 | 0.060 |
Why?
|
| Genetic Engineering | 2 | 2008 | 929 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 15308 | 0.060 |
Why?
|
| Endonucleases | 1 | 2008 | 370 | 0.060 |
Why?
|
| Cell Communication | 3 | 2007 | 1650 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 656 | 0.060 |
Why?
|
| Pathology | 1 | 2008 | 269 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 410 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2006 | 566 | 0.060 |
Why?
|
| Testosterone | 1 | 2016 | 2472 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.060 |
Why?
|
| Neural Crest | 1 | 2007 | 278 | 0.060 |
Why?
|
| Heterozygote | 2 | 2010 | 2778 | 0.060 |
Why?
|
| RNA, Small Interfering | 5 | 2017 | 3409 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2006 | 325 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2005 | 314 | 0.060 |
Why?
|
| Logistic Models | 2 | 2013 | 13254 | 0.060 |
Why?
|
| Fertility | 1 | 2009 | 768 | 0.060 |
Why?
|
| RNA Interference | 4 | 2017 | 2816 | 0.060 |
Why?
|
| Oxygen Isotopes | 1 | 2004 | 43 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 1988 | 826 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2009 | 728 | 0.060 |
Why?
|
| S Phase | 1 | 2005 | 422 | 0.060 |
Why?
|
| G1 Phase | 1 | 2005 | 403 | 0.060 |
Why?
|
| Germ-Line Mutation | 3 | 2007 | 1852 | 0.060 |
Why?
|
| Cell Survival | 5 | 2014 | 5776 | 0.060 |
Why?
|
| RNA | 3 | 2009 | 2708 | 0.060 |
Why?
|
| Young Adult | 3 | 2024 | 59199 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 18385 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 58946 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 10213 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2007 | 741 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 1668 | 0.050 |
Why?
|
| T-Lymphocytes | 7 | 1993 | 10203 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 416 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 399 | 0.050 |
Why?
|
| Lymphatic Metastasis | 3 | 2011 | 2913 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2009 | 1720 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2014 | 4137 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2021 | 41486 | 0.050 |
Why?
|
| Sulfones | 1 | 2006 | 448 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 1269 | 0.050 |
Why?
|
| Hyperglycemia | 2 | 2002 | 1375 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2004 | 212 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1744 | 0.050 |
Why?
|
| K562 Cells | 2 | 2019 | 640 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1472 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 1994 | 812 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 725 | 0.050 |
Why?
|
| Male | 20 | 2024 | 360675 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2813 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3925 | 0.050 |
Why?
|
| Blotting, Western | 5 | 2016 | 5033 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 613 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2010 | 11505 | 0.050 |
Why?
|
| Immunoglobulins | 2 | 1998 | 851 | 0.050 |
Why?
|
| Microsatellite Instability | 2 | 2017 | 716 | 0.050 |
Why?
|
| Cell Proliferation | 6 | 2017 | 10421 | 0.050 |
Why?
|
| Receptors, Transferrin | 1 | 2003 | 291 | 0.050 |
Why?
|
| Nipples | 1 | 2004 | 229 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2003 | 309 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2138 | 0.050 |
Why?
|
| Enzymes | 1 | 2003 | 252 | 0.050 |
Why?
|
| Dissection | 2 | 2001 | 297 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2005 | 573 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 1822 | 0.050 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 2001 | 17 | 0.050 |
Why?
|
| Cell Cycle Proteins | 5 | 2013 | 3443 | 0.050 |
Why?
|
| Rats | 8 | 2011 | 23713 | 0.050 |
Why?
|
| Spleen | 1 | 2007 | 2290 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2016 | 1682 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2007 | 1012 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1696 | 0.050 |
Why?
|
| Base Sequence | 7 | 2012 | 12404 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2003 | 394 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 371 | 0.050 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2001 | 117 | 0.050 |
Why?
|
| COS Cells | 2 | 2001 | 1129 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39121 | 0.040 |
Why?
|
| Gene Frequency | 3 | 2014 | 3603 | 0.040 |
Why?
|
| Oncogenes | 1 | 2006 | 1220 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2010 | 3430 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2017 | 1644 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2007 | 2846 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2001 | 143 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12058 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2001 | 2741 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2001 | 199 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 411 | 0.040 |
Why?
|
| Cell Separation | 3 | 2014 | 1718 | 0.040 |
Why?
|
| Spinal Cord | 2 | 1988 | 1807 | 0.040 |
Why?
|
| Azacitidine | 1 | 2001 | 336 | 0.040 |
Why?
|
| Carcinogens | 1 | 2021 | 452 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2002 | 591 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 1743 | 0.040 |
Why?
|
| Integrins | 1 | 2003 | 834 | 0.040 |
Why?
|
| Jews | 2 | 2002 | 356 | 0.040 |
Why?
|
| Time Factors | 3 | 2017 | 39953 | 0.040 |
Why?
|
| Receptor, Notch1 | 2 | 2016 | 497 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 13404 | 0.040 |
Why?
|
| DNA Methylation | 4 | 2010 | 4386 | 0.040 |
Why?
|
| Autoimmune Diseases | 2 | 1988 | 2243 | 0.040 |
Why?
|
| Cicatrix | 1 | 2004 | 793 | 0.040 |
Why?
|
| Indoles | 1 | 2006 | 1830 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2017 | 203 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 1999 | 739 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 1681 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1998 | 174 | 0.040 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 161 | 0.040 |
Why?
|
| Binding Sites | 4 | 2003 | 5993 | 0.040 |
Why?
|
| Receptors, Steroid | 1 | 2017 | 156 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 1066 | 0.030 |
Why?
|
| Incidence | 2 | 2013 | 21357 | 0.030 |
Why?
|
| Phenotype | 5 | 2016 | 16572 | 0.030 |
Why?
|
| Isoquinolines | 2 | 1989 | 352 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 404 | 0.030 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 1996 | 110 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 2061 | 0.030 |
Why?
|
| Computational Biology | 1 | 2008 | 3499 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 287 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2002 | 1120 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3790 | 0.030 |
Why?
|
| Sheep | 1 | 1999 | 1436 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4739 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 1658 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2017 | 221 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2022 | 1967 | 0.030 |
Why?
|
| DNA Primers | 3 | 2006 | 2815 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2001 | 3725 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2001 | 851 | 0.030 |
Why?
|
| ras Proteins | 2 | 2011 | 1054 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2016 | 115 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2006 | 1458 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 182 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2011 | 8164 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 2896 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1995 | 67 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2003 | 1605 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2017 | 385 | 0.030 |
Why?
|
| Colonic Neoplasms | 2 | 2004 | 2528 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2004 | 4111 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 287 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2011 | 2666 | 0.030 |
Why?
|
| Amino Acids | 1 | 2000 | 1703 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1995 | 286 | 0.030 |
Why?
|
| Toremifene | 1 | 2014 | 24 | 0.030 |
Why?
|
| Enzyme Activators | 1 | 2014 | 57 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2010 | 1126 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 2017 | 573 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1995 | 455 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2014 | 104 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 4021 | 0.030 |
Why?
|
| Genes, p53 | 2 | 2010 | 713 | 0.030 |
Why?
|
| Genetic Markers | 3 | 2008 | 2599 | 0.030 |
Why?
|
| Protein Kinase C | 2 | 1989 | 1202 | 0.030 |
Why?
|
| Brain Death | 1 | 2017 | 357 | 0.030 |
Why?
|
| West Indies | 1 | 2013 | 32 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3577 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 1997 | 663 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 11103 | 0.030 |
Why?
|
| Glycosylation | 1 | 1996 | 1095 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 1992 | 2549 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Adenoma | 1 | 2004 | 2159 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 1745 | 0.030 |
Why?
|
| Exons | 2 | 2011 | 2380 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1087 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2016 | 10083 | 0.030 |
Why?
|
| Proteins | 2 | 2011 | 5993 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2008 | 925 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 42 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 2012 | 157 | 0.030 |
Why?
|
| Androstadienes | 1 | 2014 | 348 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 448 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 1964 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 550 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 809 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2012 | 123 | 0.020 |
Why?
|
| DNA | 3 | 2003 | 7189 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 112 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 11856 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1996 | 1875 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2002 | 283 | 0.020 |
Why?
|
| Genomics | 1 | 2008 | 5828 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2012 | 144 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1240 | 0.020 |
Why?
|
| Lymphocyte Activation | 5 | 1992 | 5478 | 0.020 |
Why?
|
| Latin America | 1 | 2013 | 412 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 581 | 0.020 |
Why?
|
| Vietnam | 1 | 2012 | 406 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 731 | 0.020 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2011 | 37 | 0.020 |
Why?
|
| Purines | 1 | 2014 | 609 | 0.020 |
Why?
|
| Gene Silencing | 3 | 2002 | 1496 | 0.020 |
Why?
|
| Malate Dehydrogenase | 1 | 2011 | 40 | 0.020 |
Why?
|
| Receptors, Vitronectin | 1 | 2010 | 46 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2012 | 200 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1993 | 406 | 0.020 |
Why?
|
| Porosity | 1 | 2011 | 348 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 9518 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 4853 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 283 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2012 | 1891 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 250 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2010 | 103 | 0.020 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 60 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 467 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2002 | 2020 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2011 | 2915 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 757 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 355 | 0.020 |
Why?
|
| Microcirculation | 1 | 2014 | 1280 | 0.020 |
Why?
|
| Species Specificity | 1 | 1994 | 2406 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 673 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2011 | 218 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2013 | 544 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 563 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2013 | 17889 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2017 | 1730 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 411 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 2012 | 2974 | 0.020 |
Why?
|
| Keratins | 1 | 2010 | 498 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1994 | 1243 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 5775 | 0.020 |
Why?
|
| Microfluidics | 1 | 2014 | 651 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2005 | 1138 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2009 | 146 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2009 | 189 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2009 | 153 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1831 | 0.020 |
Why?
|
| Coliphages | 1 | 2008 | 121 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6340 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1999 | 5249 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1991 | 897 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2010 | 18926 | 0.020 |
Why?
|
| Epitopes | 2 | 1992 | 2503 | 0.020 |
Why?
|
| Gene Library | 2 | 2001 | 1055 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 252 | 0.020 |
Why?
|
| Alleles | 2 | 2014 | 6857 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 5366 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2010 | 526 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1989 | 303 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 2009 | 174 | 0.020 |
Why?
|
| Sweden | 1 | 2011 | 1379 | 0.020 |
Why?
|
| Isoleucine | 1 | 2007 | 110 | 0.020 |
Why?
|
| Hawaii | 1 | 2007 | 101 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2011 | 555 | 0.020 |
Why?
|
| Child | 1 | 2016 | 80134 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 748 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2005 | 696 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4574 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 475 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 2091 | 0.020 |
Why?
|
| Pyridines | 1 | 2019 | 2872 | 0.020 |
Why?
|
| Kinetics | 1 | 1995 | 6312 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2010 | 324 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 88271 | 0.020 |
Why?
|
| Recurrence | 2 | 2013 | 8456 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2011 | 709 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2410 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 270 | 0.020 |
Why?
|
| Melanoma | 1 | 2005 | 5694 | 0.020 |
Why?
|
| Histidine | 1 | 2007 | 303 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2008 | 1139 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3779 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5318 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 590 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 1662 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 1004 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2007 | 437 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6507 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2010 | 654 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2452 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7386 | 0.020 |
Why?
|
| Leucine | 1 | 2007 | 547 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12145 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2005 | 5809 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 9001 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 677 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 455 | 0.020 |
Why?
|
| Age of Onset | 2 | 2007 | 3307 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2024 | 0.020 |
Why?
|
| Mimosine | 1 | 2005 | 7 | 0.020 |
Why?
|
| Aphidicolin | 1 | 2005 | 37 | 0.020 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2005 | 94 | 0.020 |
Why?
|
| Survival Rate | 2 | 2013 | 12727 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3550 | 0.020 |
Why?
|
| Vinblastine | 1 | 2007 | 488 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2005 | 186 | 0.020 |
Why?
|
| Cell Shape | 1 | 2006 | 370 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2006 | 1083 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2006 | 202 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 838 | 0.020 |
Why?
|
| Liver | 1 | 2000 | 7513 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1602 | 0.010 |
Why?
|
| Genes, ras | 1 | 2007 | 654 | 0.010 |
Why?
|
| Calcium | 2 | 1995 | 5720 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 12983 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2011 | 1231 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2005 | 317 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2008 | 1227 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 359 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1761 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2010 | 6390 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 904 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2508 | 0.010 |
Why?
|
| Succinimides | 1 | 2003 | 81 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2013 | 1247 | 0.010 |
Why?
|
| Genes, p16 | 1 | 2004 | 160 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2005 | 276 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2004 | 319 | 0.010 |
Why?
|
| Trypsin | 1 | 2004 | 486 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2010 | 14393 | 0.010 |
Why?
|
| Retroviridae | 1 | 2005 | 850 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2005 | 454 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 247 | 0.010 |
Why?
|
| Protein Binding | 2 | 2008 | 9300 | 0.010 |
Why?
|
| Sirolimus | 1 | 2010 | 1540 | 0.010 |
Why?
|
| Cell Division | 3 | 2001 | 4451 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2002 | 121 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2005 | 598 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2926 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 225 | 0.010 |
Why?
|
| Antioxidants | 1 | 2010 | 1667 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3832 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2003 | 378 | 0.010 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2001 | 21 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2002 | 649 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2002 | 216 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1133 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2007 | 2219 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 525 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2004 | 348 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 319 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2001 | 97 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 254 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 323 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2008 | 3936 | 0.010 |
Why?
|
| Genetic Testing | 2 | 2006 | 3536 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 1553 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 655 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2004 | 642 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1987 | 1891 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 517 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2005 | 727 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14676 | 0.010 |
Why?
|
| Models, Biological | 2 | 2008 | 9455 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2562 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2004 | 559 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2007 | 2224 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 374 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 265 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 502 | 0.010 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 18217 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1544 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 826 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2643 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 435 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 418 | 0.010 |
Why?
|
| Cricetulus | 1 | 2001 | 812 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4922 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7574 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2014 | 6565 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 908 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2011 | 5103 | 0.010 |
Why?
|
| Algorithms | 2 | 2012 | 14023 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 2000 | 308 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 1989 | 56 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1379 | 0.010 |
Why?
|
| Family | 1 | 2009 | 3193 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3819 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 5413 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2007 | 2242 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2013 | 3801 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12670 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2412 | 0.010 |
Why?
|
| Glutamine | 1 | 2000 | 574 | 0.010 |
Why?
|
| Actins | 1 | 2005 | 2046 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6781 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1987 | 1977 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2002 | 811 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1498 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 646 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10758 | 0.010 |
Why?
|
| Prevalence | 2 | 2009 | 15717 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2175 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 1696 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 921 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2189 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 2003 | 710 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 4423 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 3196 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3114 | 0.010 |
Why?
|
| CpG Islands | 1 | 2001 | 1190 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 1480 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4353 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3598 | 0.010 |
Why?
|
| Forecasting | 1 | 2005 | 2928 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4618 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 1987 | 0.010 |
Why?
|
| Reoperation | 1 | 2006 | 4304 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2010 | 3481 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1994 | 326 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 2801 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1991 | 4168 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1997 | 823 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6198 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2002 | 1945 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 9185 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4537 | 0.010 |
Why?
|
| Psoriasis | 1 | 2002 | 945 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2005 | 2316 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 2475 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 36418 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20120 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8519 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2802 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 294 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1993 | 167 | 0.010 |
Why?
|
| Energy Intake | 1 | 2000 | 2133 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3429 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 411 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2160 | 0.010 |
Why?
|
| Stem Cells | 1 | 2005 | 3512 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 5077 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 1991 | 193 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 1615 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 7969 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 4341 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1989 | 104 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2005 | 4642 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 3535 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1535 | 0.010 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1988 | 14 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 22129 | 0.000 |
Why?
|
| Tuberculin | 1 | 1988 | 64 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 563 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 548 | 0.000 |
Why?
|
| Boston | 1 | 2001 | 9324 | 0.000 |
Why?
|
| Thymoma | 1 | 1989 | 188 | 0.000 |
Why?
|
| Aging | 1 | 2006 | 8701 | 0.000 |
Why?
|
| Autoradiography | 1 | 1988 | 729 | 0.000 |
Why?
|
| Insulin | 1 | 2002 | 6588 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1993 | 3073 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9317 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1301 | 0.000 |
Why?
|
| Ovalbumin | 1 | 1988 | 671 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1991 | 3060 | 0.000 |
Why?
|
| Mass Screening | 1 | 2001 | 5425 | 0.000 |
Why?
|
| Contrast Media | 1 | 1997 | 5311 | 0.000 |
Why?
|
| United States | 1 | 2007 | 72337 | 0.000 |
Why?
|